Medicare Enrolled

Dr. Kimberly Lucas Slimane, N.P.

Acute Care Nurse Practitioner · San Antonio, TX
Low-engagement
21 SPURS LN STE 230B, San Antonio, TX 78240
2106907400
In practice since 2009 (16 years)
NPI: 1003042573 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lucas Slimane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucas Slimane? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lucas Slimane

Dr. Kimberly Lucas Slimane is an acute care nurse practitioner in San Antonio, TX, with 16 years of NPI registration.

Between the years covered by Open Payments, Dr. Lucas Slimane received a total of $8,517 from 38 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in acute care nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lucas Slimane is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice $8,517 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,517
Total received (2021-2024)
Avg $2,129/year across 4 years
Top 2% in TX for acute care nurse practitioner
38
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,517 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,155
2023
$2,051
2022
$2,517
2021
$1,794

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,664
AstraZeneca Pharmaceuticals LP
$1,552
Boehringer Ingelheim Pharmaceuticals, Inc.
$790
Mylan Specialty L.P.
$629
Grifols USA, LLC
$446
ABBVIE INC.
$384
Electromed, Inc.
$335
Baxter Healthcare
$308
Janssen Pharmaceuticals, Inc
$224
GENZYME CORPORATION
$193
Insmed, Inc.
$183
Takeda Pharmaceuticals U.S.A., Inc.
$156
Actelion Pharmaceuticals US, Inc.
$153
Tactile Systems Technology Inc
$147
United Therapeutics Corporation
$143
Philips Electronics North America Corporation
$139
Regeneron Healthcare Solutions, Inc.
$133
JAZZ PHARMACEUTICALS INC.
$122
Novartis Pharmaceuticals Corporation
$108
Genentech USA, Inc.
$79
Fisher & Paykel Healthcare Inc
$68
Philips North America LLC
$64
Medtronic, Inc.
$60
Axsome Therapeutics, Inc.
$54
Inspire Medical Systems, Inc.
$48
Harmony Biosciences LLC
$47
Advanced Respiratory, Inc
$43
Amgen Inc.
$42
Gilead Sciences, Inc.
$42
Harmony Biosciences Llc
$21
Teva Pharmaceuticals USA, Inc.
$21
Merck Sharp & Dohme LLC
$19
PFIZER INC.
$19
Mallinckrodt Hospital Products Inc.
$18
ANI Pharmaceuticals, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
ALK-Abello, Inc
$16
Shionogi Inc
$14
Top 3 companies account for 47.0% of total payments
Associated products mentioned in payments ›
(2383) SleepUndivided · (7999) SRC Und · (8269) Dreamstat Cpap · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BREZTRI · DALVANCE · DUPIXENT · ELIQUIS · FASENRA · FISHER & PAYKEL HEALTHCARE · Fetroja · Flexitouch Plus · GLASSIA · Grastek · HAWKONE · HORIZANT · HawkOne · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · INSPIRE · LIBTAYO · LUMAKRAS · NUCALA · OFEV · OPSUMIT · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · The Vest System 205 Acute Care · UPTRAVI · Veklury · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for acute care nurse practitioner in TX.

Looking for an acute care nurse practitioner in San Antonio?
Compare acute care nurse practitioners in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse acute care nurse practitioners nearby

Geographic Context

Acute care nurse practitioners within 10 mi
263
Per 100K population
12.9
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lucas Slimane is an acute care nurse practitioner, with low-engagement industry engagement in the top 2% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lucas Slimane receive payments from pharmaceutical companies?
Yes. Dr. Lucas Slimane received a total of $8,517 from 38 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lucas Slimane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Acute Care Nurse Practitioners in San Antonio
Browse acute care nurse practitioners in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Acute Care Nurse Practitioners in TX
Acute care nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Acute Care Nurse Practitioners in TX
Which TX acute care nurse practitioners receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →